2010
February
| February 2 | |
| From Comprehensive Genomics to the Discovery of New Therapeutic Targets in High-Risk Acute Lymphoblastic Leukemia—The Impact of Race and Outcome | Cheryl L. Willman, M.D. The Maurice and Marguerite Liberman Distinguished Chair in Cancer Research Professor of Pathology and Medicine Director & CEO, University of New Mexico Cancer Research & Treatment Center UNM Cancer Research Facility Albuquerque, N. Mex. |
| February 9 | |
| No Lecture | NCAB February 8–10 |
| February 16 | |
| Recombinant Immunotoxins for the Treatment of B-cell Malignancies and Mesothelioma: A Clinical and Laboratory Update | Ira Pastan, M.D. Chief, Laboratory of Molecular Biology Center for Cancer Research, NCI Bethesda, Md. |
| February 23 | |
| Genetic Predictors of RAF/MEK Dependence | David Solit, M.D. Elizabeth and Felix Rohatyn Chair Department of Medicine, Genitourinary Oncology Service Memorial Sloan-Kettering Cancer Center New York, N.Y. |
General information about Grand Rounds
Lipsett Amphitheater, Building 10, 8:00 - 9:00 a.m.
Telephone Contact: 301-984-7191
Educational Objectives
After attending this activity, the participant should be able to describe the novel aspects of the basic and/or clinical research in cancer prevention, diagnosis or treatment presented by the speaker. Participants should also be able to discuss the potential applications of the research and/or therapeutic approaches presented by the speaker and the impact that this is likely to have in advancing the field of oncology research and practice.
If you are an individual with a disability who needs any assistance or assistive devices to participate in this event, please call Karen Davison at 301-984-7191 by the Thursday prior to the seminar so that we can discuss your needs.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
Public Health Service
National Institutes of Health
Back to Top
